NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Developer of health care devices designed to help people with Parkinson's improve their quality of life. The company develops a non-invasive wearable device that modulates sensory dysfunction, helping people with Parkinson's disease to improve their movement speed while living a normal life.
Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development and manufacture of lithium-ion batteries for mobile devices and the automotive industry. Founded in 2017 as a spinout from the University of Cambridge Engineering Department, Echion leverages proprietary battery active materials to create next-generation batteries. The company's focus is on producing anode materials designed to facilitate fast charging for electric vehicles, promoting sustainable electrification across various applications. By optimizing power anode materials, Echion aims to provide cost-effective solutions for battery production, contributing to a more sustainable future in energy storage and usage.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Riverlane is the most advanced quantum computing software developer
Cambridge GaN Devices is a developer of semiconductors focused on designing, creating, and commercializing gallium nitride-based power devices. The company's transistors offer higher speed, significantly lower power loss, and reduced size compared to traditional silicon alternatives. These advancements result in lower energy consumption and enhanced power storage and conversion capabilities. As a result, Cambridge GaN Devices provides industries with compact semiconductors tailored for critical applications across various market segments.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market. The company specializes in rapid set liquid barriers.
Nu Quantum Ltd is a Cambridge-based company that specializes in the development of quantum photonics hardware, including photon sources and detectors, as well as quantum cryptography systems. Founded in 2018, the company focuses on creating nano-engineered materials that facilitate light generation at the quantum level and enable ultra-sensitive light detection. It also develops fundamental algorithms and protocols for generating secure cryptographic keys and offers quantum encryption links for secure communications. By integrating novel materials and semiconductor technology, Nu Quantum aims to provide end-to-end quantum cryptography solutions that secure communications over urban and satellite free-space optical links, thereby supporting the future of information processing and quantum networking infrastructure.
Quantum Motion Technologies Limited is focused on developing a universal quantum computer utilizing silicon-based technology and CMOS-compatible processes. Founded in 2017 and based in Leeds, United Kingdom, the company aims to create scalable quantum computing architectures that address issues such as fault tolerance and qubit redundancy. Its technology is designed to enhance qubit density, allowing for the construction of large-scale quantum systems capable of solving complex problems in various fields, including chemistry, medicine, and artificial intelligence. By leveraging advanced architectural approaches, Quantum Motion Technologies seeks to advance the quantum technology sector and provide solutions that reduce errors and overcome critical challenges in quantum information processing.
PharmEnable Limited is a drug discovery company based in Cambridge, United Kingdom, that was incorporated in 2016. The company specializes in using medicinal chemistry and artificial intelligence to design small molecule drugs. PharmEnable has developed a rapid and cost-effective method for identifying improved chemical starting points, which aims to enhance the discovery of essential new medicines.
Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development and manufacture of lithium-ion batteries for mobile devices and the automotive industry. Founded in 2017 as a spinout from the University of Cambridge Engineering Department, Echion leverages proprietary battery active materials to create next-generation batteries. The company's focus is on producing anode materials designed to facilitate fast charging for electric vehicles, promoting sustainable electrification across various applications. By optimizing power anode materials, Echion aims to provide cost-effective solutions for battery production, contributing to a more sustainable future in energy storage and usage.
Manufacturer and developer of organic photovoltaic devices designed to enhance next-generation solar technology. The company's devices engage in the deployment of off-grid solar power and use advanced nanotechnology to split each incoming blue and green photon into two infra-red photons, enabling clients to deploy solar power through lightweight devices whenever needed.
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Cambridge GaN Devices is a developer of semiconductors focused on designing, creating, and commercializing gallium nitride-based power devices. The company's transistors offer higher speed, significantly lower power loss, and reduced size compared to traditional silicon alternatives. These advancements result in lower energy consumption and enhanced power storage and conversion capabilities. As a result, Cambridge GaN Devices provides industries with compact semiconductors tailored for critical applications across various market segments.
PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.
Aqdot Limited, founded in 2012 and located in Cambridge, United Kingdom, specializes in the manufacturing of smart microcapsules with customizable properties tailored for various industries. The company has developed a unique one-step shrink-wrap approach that combines emulsion technology and supramolecular chemistry, simplifying the microencapsulation process. This innovative technology promotes energy and raw material efficiency, resulting in reduced energy consumption and waste production. Aqdot's microcapsules have potential applications across multiple sectors, including encapsulating enzymes for laundry detergents and fertilizers in agriculture. The microencapsulation market is substantial, with established uses in household and personal care products, food, and agrochemicals.
Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development and manufacture of lithium-ion batteries for mobile devices and the automotive industry. Founded in 2017 as a spinout from the University of Cambridge Engineering Department, Echion leverages proprietary battery active materials to create next-generation batteries. The company's focus is on producing anode materials designed to facilitate fast charging for electric vehicles, promoting sustainable electrification across various applications. By optimizing power anode materials, Echion aims to provide cost-effective solutions for battery production, contributing to a more sustainable future in energy storage and usage.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
OxSyBio Ltd. specializes in developing advanced 3D printing techniques to create tissue-like and functional tissues for medical research and clinical applications. The company focuses on producing innovative materials made up of three-dimensional networks of lipid monolayer aqueous droplets. These materials can conduct electrical signals along designated pathways and have the ability to self-fold into complex geometries. This technology has potential applications in regenerative medicine, including organ repair and replacement, aiming to enhance precision medicine. Founded in 2014 and based in London, OxSyBio draws upon cutting-edge research from Professor Hagan Bayley's group at the University of Oxford, known for its expertise in chemical and synthetic biology.
Quantum Motion Technologies Limited is focused on developing a universal quantum computer utilizing silicon-based technology and CMOS-compatible processes. Founded in 2017 and based in Leeds, United Kingdom, the company aims to create scalable quantum computing architectures that address issues such as fault tolerance and qubit redundancy. Its technology is designed to enhance qubit density, allowing for the construction of large-scale quantum systems capable of solving complex problems in various fields, including chemistry, medicine, and artificial intelligence. By leveraging advanced architectural approaches, Quantum Motion Technologies seeks to advance the quantum technology sector and provide solutions that reduce errors and overcome critical challenges in quantum information processing.
Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies.
Ionix Advanced Technologies Ltd. specializes in the development and supply of high-performance piezoelectric devices and materials designed for high-temperature applications. Founded in 2011 and based in Leeds, United Kingdom, the company offers a diverse range of products, including sensors, actuators, and transducer devices that utilize its advanced piezoelectric materials. These devices are engineered to operate effectively in extreme environments, making them suitable for various industries such as aerospace, oil and gas, nuclear power, automotive, and non-destructive testing (NDT). Ionix's technology aims to reduce energy and operating costs while enhancing reliability and safety, particularly in applications requiring continuous operation under challenging conditions, including high temperatures and ionizing radiation.
NuNano is a UK-based company founded in 2011 that specializes in the design and manufacture of probes for atomic force microscopy (AFM) and cantilever-based sensor devices. Established by Dr. James Vicary and Professors Heinrich Hoerber and Mervyn Miles, the company aims to modernize an industry that has seen little innovation over the past two decades. NuNano leverages proprietary microfabrication processes to produce AFM probes with exceptionally tight dimensional tolerances, positioning itself as a leader in precision within the market. These advanced probes facilitate the investigation of nano-scale properties of materials across various applications, including quality control in the semiconductor sector and research in molecular biology. The company is committed to delivering exemplary customer service, ensuring a positive experience for users from their initial website visit to the usage of their products in research and analysis.
Exonate Limited is a private biotech company based in Duxford, United Kingdom, specializing in the discovery and development of small molecule drugs aimed at modulating alternative messenger RNA splicing for ophthalmological applications. Founded in 2013, the company emerged from the University of Nottingham and is focused on addressing retinal vascular diseases, particularly diabetic macular oedema (DMO) and wet age-related macular degeneration (wAMD). Exonate's lead program utilizes small molecule inhibitors that selectively target serine/threonine-protein kinase 1 to inhibit the production of pro-angiogenic vascular endothelial growth factor (VEGF) splice variants. This innovative approach aims to improve therapeutic outcomes and offers a potential alternative to current treatment methods, such as anti-VEGF injections and laser surgery. With a preclinical candidate drug already nominated, Exonate is advancing its research through regulatory toxicology and safety pharmacology studies to facilitate clinical evaluation. The company is backed by an experienced management team with expertise in medicine and drug development.
Fluidic Analytics Limited designs, develops, and manufactures equipment for the characterization of proteins in laboratory, medical, and consumer applications. The company provides Fluidity One, a product that enables in-solution sizing and quantification of native protein. The company also offers Fluidity One-W, a product that enables high sensitivity in-solution analysis of protein size and protein interaction kinetics. Its products are used for applications, including protein quality, interactions, aggregation, and sizing. The company serves scientists, clinics, and healthcare providers. Fluidic Analytics Limited was founded in 2013 and is based in Cambridge, United Kingdom.
Micrima Ltd. spun out from research at the University of Bristol. The Micrima team is developnig radio-wave technology for detecting breast cancer. The technology is non-invasive, non-ionising and inexpensive.
The imaging technology has received extensive validation in the laboratory and is now undergoing first human use trials.
Microsaic Systems specializes in the research, development, and commercialization of miniaturized mass spectrometry instruments, utilizing micro-electro-mechanical systems technology. The company offers a range of products including the MiD platform solutions, which cater to pharmaceutical and biopharmaceutical applications, as well as automated sampling interfaces and specialized mass spectrometers. Their technology has diverse applications such as liquid chromatography, process analytical technology, and mass-directed purification. In addition to selling instruments, Microsaic provides support services, training programs, and collaborates with original equipment manufacturers and distributors. The company is also expanding its focus to include the integration of artificial intelligence and Internet of Things analytical sensors, aiming to generate recurring revenue in sectors like bioprocessing, environmental monitoring, and health, with potential extensions into aviation, food, and oil industries. Headquartered in Woking, United Kingdom, Microsaic Systems was incorporated in 1998.
Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Xerion Healthcare Limited is a UK-based company focused on developing and commercializing nanoparticle treatments to enhance the effectiveness of cancer therapies, specifically targeting head, neck, and pancreatic tumors. Founded in 2015, the company utilizes titanium dioxide nanoparticles, a non-toxic semiconductor material, which are injected into tumors prior to standard radiotherapy. This innovative approach amplifies the dose of free radicals produced by X-rays, thereby improving the treatment's efficacy while minimizing potential side effects. By integrating this nanomedicine technology into conventional radiotherapy, Xerion Healthcare aims to provide more effective solutions for patients with challenging cancer types.
Ionix Advanced Technologies Ltd. specializes in the development and supply of high-performance piezoelectric devices and materials designed for high-temperature applications. Founded in 2011 and based in Leeds, United Kingdom, the company offers a diverse range of products, including sensors, actuators, and transducer devices that utilize its advanced piezoelectric materials. These devices are engineered to operate effectively in extreme environments, making them suitable for various industries such as aerospace, oil and gas, nuclear power, automotive, and non-destructive testing (NDT). Ionix's technology aims to reduce energy and operating costs while enhancing reliability and safety, particularly in applications requiring continuous operation under challenging conditions, including high temperatures and ionizing radiation.
Surrey NanoSystems Limited is a manufacturer of nanoscale materials, specializing in advanced super-black coatings, notably Vantablack. This innovative coating is applied to surfaces using vacuum-deposition technology, as well as through spraying and post-processing methods. Vantablack is utilized in a diverse array of applications, including stray light suppression, architectural lighting, sensors, telescopes, infrared imaging systems, and cinematography optics. Additionally, the coating enhances the performance of sensitive electro-optical imaging systems, making it valuable in sectors such as aerospace, automotive safety, architecture, and luxury goods. Founded in 2006 and headquartered in Newhaven, United Kingdom, Surrey NanoSystems was previously known as CEVP Limited before adopting its current name in December 2006.
Fluidic Analytics Limited designs, develops, and manufactures equipment for the characterization of proteins in laboratory, medical, and consumer applications. The company provides Fluidity One, a product that enables in-solution sizing and quantification of native protein. The company also offers Fluidity One-W, a product that enables high sensitivity in-solution analysis of protein size and protein interaction kinetics. Its products are used for applications, including protein quality, interactions, aggregation, and sizing. The company serves scientists, clinics, and healthcare providers. Fluidic Analytics Limited was founded in 2013 and is based in Cambridge, United Kingdom.
Nandi Proteins Limited is a technology-driven company based in Edinburgh, United Kingdom, focused on enhancing the functional properties of proteins in food manufacturing and nutrition. Established in 2000 and spun out of Heriot Watt University in 2001, the company specializes in patented processes that improve common proteins such as whey, egg, and soy. Nandi Proteins aims to be a leader in denatured protein technology, facilitating growth through direct trading of value-added proteins and strategic licensing agreements with industry partners. Its innovative approach employs a combination of heat, time, and temperature control to modify proteins, enabling food and beverage manufacturers to achieve desirable characteristics and health benefits while efficiently extracting valuable components like enzymes.
Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.
Xeros Technology Group develops and commercializes innovative polymer-based technologies aimed at reducing water consumption in various cleaning applications across Europe and North America. The company focuses on creating alternatives to traditional aqueous cleaning methods, particularly for fabric and garment manufacturing as well as industrial and domestic laundry. Key products include XOrbs, which provide mechanical action to remove dirt and stains, XDrum for fabric manufacturing, and XFiltra, which de-waters filtered materials for easier disposal. Founded in 2013 and based in Rotherham, United Kingdom, Xeros leverages over 30 years of research from the University of Leeds to advance its "virtually waterless" laundry cleaning solutions, contributing to significant cost savings and improved environmental sustainability in the cleaning industry.
Aqdot Limited, founded in 2012 and located in Cambridge, United Kingdom, specializes in the manufacturing of smart microcapsules with customizable properties tailored for various industries. The company has developed a unique one-step shrink-wrap approach that combines emulsion technology and supramolecular chemistry, simplifying the microencapsulation process. This innovative technology promotes energy and raw material efficiency, resulting in reduced energy consumption and waste production. Aqdot's microcapsules have potential applications across multiple sectors, including encapsulating enzymes for laundry detergents and fertilizers in agriculture. The microencapsulation market is substantial, with established uses in household and personal care products, food, and agrochemicals.
Microsaic Systems specializes in the research, development, and commercialization of miniaturized mass spectrometry instruments, utilizing micro-electro-mechanical systems technology. The company offers a range of products including the MiD platform solutions, which cater to pharmaceutical and biopharmaceutical applications, as well as automated sampling interfaces and specialized mass spectrometers. Their technology has diverse applications such as liquid chromatography, process analytical technology, and mass-directed purification. In addition to selling instruments, Microsaic provides support services, training programs, and collaborates with original equipment manufacturers and distributors. The company is also expanding its focus to include the integration of artificial intelligence and Internet of Things analytical sensors, aiming to generate recurring revenue in sectors like bioprocessing, environmental monitoring, and health, with potential extensions into aviation, food, and oil industries. Headquartered in Woking, United Kingdom, Microsaic Systems was incorporated in 1998.
Xeros Technology Group develops and commercializes innovative polymer-based technologies aimed at reducing water consumption in various cleaning applications across Europe and North America. The company focuses on creating alternatives to traditional aqueous cleaning methods, particularly for fabric and garment manufacturing as well as industrial and domestic laundry. Key products include XOrbs, which provide mechanical action to remove dirt and stains, XDrum for fabric manufacturing, and XFiltra, which de-waters filtered materials for easier disposal. Founded in 2013 and based in Rotherham, United Kingdom, Xeros leverages over 30 years of research from the University of Leeds to advance its "virtually waterless" laundry cleaning solutions, contributing to significant cost savings and improved environmental sustainability in the cleaning industry.
Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.
ReInnervate Limited, a biotechnology company, engages in the development of enabling technologies that facilitate research into cell growth and function in vitro, primarily in the field of stem cell biology. Its technologies control the differentiation of stem cells and the formation of specific tissue types, as well as offers tools to develop diagnostics and treatments for neuro-degenerative diseases. The company was founded in 2002 and is based in Durham, the United Kingdom.
Natrox is a wound-care company specializing in advanced wound therapy solutions. Its primary product is a battery-operated medical device that generates a continuous flow of pure humidified oxygen from ambient air. This oxygen is directed through a specialized system to enhance the healing of chronic wounds, including diabetic foot ulcers and pressure ulcers, by ensuring a consistent supply of oxygen to the wound bed. The device allows for the efficient removal of wound fluids while maintaining an optimal healing environment. Additionally, Natrox incorporates artificial intelligence to analyze wound images, enabling healthcare providers to monitor healing progress and facilitate real-time communication regarding patient treatment. Through its innovative approach, Natrox aims to improve the quality of life for patients suffering from difficult-to-heal wounds.
Itaconix is a green technology company developing, manufacturing, and marketing environmentally-friendly polymers derived from renewable resources. The company was founded in 2008 and is based in Dover, New Hampshire.
Surrey NanoSystems Limited is a manufacturer of nanoscale materials, specializing in advanced super-black coatings, notably Vantablack. This innovative coating is applied to surfaces using vacuum-deposition technology, as well as through spraying and post-processing methods. Vantablack is utilized in a diverse array of applications, including stray light suppression, architectural lighting, sensors, telescopes, infrared imaging systems, and cinematography optics. Additionally, the coating enhances the performance of sensitive electro-optical imaging systems, making it valuable in sectors such as aerospace, automotive safety, architecture, and luxury goods. Founded in 2006 and headquartered in Newhaven, United Kingdom, Surrey NanoSystems was previously known as CEVP Limited before adopting its current name in December 2006.
ReInnervate Limited, a biotechnology company, engages in the development of enabling technologies that facilitate research into cell growth and function in vitro, primarily in the field of stem cell biology. Its technologies control the differentiation of stem cells and the formation of specific tissue types, as well as offers tools to develop diagnostics and treatments for neuro-degenerative diseases. The company was founded in 2002 and is based in Durham, the United Kingdom.
Oxyntix is a research-intensive team, developing and commercialising new technologies in energy and process engineering, among other fields. Oxyntix was spun out University and capitalises on developed and emerging know-how, intellectual property and expertise from the University and beyond
Itaconix is a green technology company developing, manufacturing, and marketing environmentally-friendly polymers derived from renewable resources. The company was founded in 2008 and is based in Dover, New Hampshire.
Xeros Technology Group develops and commercializes innovative polymer-based technologies aimed at reducing water consumption in various cleaning applications across Europe and North America. The company focuses on creating alternatives to traditional aqueous cleaning methods, particularly for fabric and garment manufacturing as well as industrial and domestic laundry. Key products include XOrbs, which provide mechanical action to remove dirt and stains, XDrum for fabric manufacturing, and XFiltra, which de-waters filtered materials for easier disposal. Founded in 2013 and based in Rotherham, United Kingdom, Xeros leverages over 30 years of research from the University of Leeds to advance its "virtually waterless" laundry cleaning solutions, contributing to significant cost savings and improved environmental sustainability in the cleaning industry.